Companies / SHPH
Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
Shuttle Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, develops novel therapies to treat cancers. It owns a pharmaceutical software artificial intelligence (AI) driven platform for molecular discovery and early-stage drug development. The company was founded in 2012 and is headquartered in Gaithersburg, Maryland.
Ticker SHPH Exchange Nasdaq Sector Healthcare Industry Drug Manufacturers - Specialty & Generic Market cap $4.31M 52-week range $2.58 - $44.40
Valuation Share price $3.82 (close of Nov 18, 2026) P/E (TTM) -0.16x Price to book 0.22x Price to free cash flow -0.65x Enterprise value $4.41M Book value per share $19.16
Price performance Period Change 1 day -11.16% 5 days -27.24% 1 month -24.80% 3 months -2.55% 6 months -38.39% Year to date -78.78% 1 year -81.90% 3 years -99.61% All time -100.00%
Short interest As of Oct 30, 2026 Short % of float 0.31% Shares short 14.96K Days to cover 0.54 Change since prior report -52.23% Source FINRA consolidated short interest
Profitability and growth Return on assets -111.89%
Cash flow and balance sheet Free cash flow yield (TTM) -152.95% Current ratio 0.11x Net debt to EBITDA -0.01x
Latest reported year Period end Dec 31, 2025 Fiscal year 2025 EBITDA -$11.63M Net income -$11.72M Research and development $4.05M
Income statement by year Period end Net income 2025-12-31 -$11.72M 2024-12-31 -$9.14M 2023-12-31 -$6.59M 2022-12-31 -$5.00M 2021-12-31 -$1.15M
Margins and returns by year Period end Return on equity Return on capital 2023-12-31 -162.55% -114.56% 2022-12-31 -65.07% -27.82%
Cash and debt by year Period end Cash Debt 2025-12-31 $334.00K - 2024-12-31 $1.92M - 2023-12-31 $2.58M $135.09K 2022-12-31 $8.42M - 2021-12-31 $504.75K $91.02K 2020-12-31 $117.15K - 2018-12-31 $352.39K - 2017-12-31 $50.71K -
Free cash flow by year Period end Free cash flow Stock-based compensation 2025-12-31 -$9.48M $932.97K 2024-12-31 -$7.33M $259.74K 2023-12-31 -$5.60M $181.96K 2022-12-31 -$2.67M $237.55K 2021-12-31 -$300.34K $910.07K 2020-12-31 -$37.65K $459.59K 2018-12-31 -$566.69K - 2017-12-31 -$202.71K -
Investor relations Next earnings report Next confirmed report Nov 19, 2026 Past earnings dates Reported Fiscal period EPS estimate 2026-11-12 Sep 2026 - 2026-09-24 Jun 2026 - 2026-05-15 Mar 2026 - 2025-11-13 Sep 2025 - 2025-08-12 Jun 2025 - 2025-05-08 Mar 2025 - 2024-11-13 Sep 2024 - 2024-09-03 Jun 2024 -
Filings and sources Company website shuttlepharma.com SEC filings 10-K, 10-Q and 8-K on EDGAR Earnings calendar All upcoming reports
Similar companies Teva Pharmaceutical Industries Ltd (TEVA) · Zoetis Inc. (ZTS) · Viatris Inc (VTRS) · Hims & Hers Health, Inc. (HIMS) · Haleon plc (HLN) · Thermo Fisher Scientific Inc. (TMO) · Danaher Corp (DHR) · Natera, Inc. (NTRA)
All Healthcare companies
Understanding these figures
Price-to-earnings ratio · Short interest · Discounted cash flow · Free cash flow · Earnings per share · Return on equity · Gross margin vs net margin · Reading a balance sheet · Debt and leverage · Dividend yield · Insider transactions and Form 4 · How to read a stock chart
Explore
Company directory · S&P 500 heatmap · Earnings calendar · Super investor holdings · Congress trades